Australia markets close in 5 hours 36 minutes

Oramed Pharmaceuticals Inc. (ORMP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.3800-0.0500 (-2.06%)
At close: 04:00PM EDT
2.3700 -0.01 (-0.42%)
After hours: 05:46PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 98.46M
Enterprise value -11.96M
Trailing P/E 17.36
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)73.57
Price/book (mrq)0.60
Enterprise value/revenue -8.93
Enterprise value/EBITDA -1.63

Trading information

Stock price history

Beta (5Y monthly) 1.86
52-week change 3-13.83%
S&P500 52-week change 325.59%
52-week high 35.2500
52-week low 31.6700
50-day moving average 32.6880
200-day moving average 32.6135

Share statistics

Avg vol (3-month) 3146.63k
Avg vol (10-day) 376.23k
Shares outstanding 540.52M
Implied shares outstanding 640.52M
Float 836.7M
% held by insiders 111.30%
% held by institutions 113.61%
Shares short (15 Apr 2024) 4367.6k
Short ratio (15 Apr 2024) 43.11
Short % of float (15 Apr 2024) 41.00%
Short % of shares outstanding (15 Apr 2024) 40.91%
Shares short (prior month 15 Mar 2024) 4484.01k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 323 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 412.31%
Operating margin (ttm)-1,176.79%

Management effectiveness

Return on assets (ttm)-5.16%
Return on equity (ttm)3.24%

Income statement

Revenue (ttm)1.34M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)-100.00%
Gross profit (ttm)N/A
EBITDA -15.57M
Net income avi to common (ttm)5.53M
Diluted EPS (ttm)0.1400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)162.05M
Total cash per share (mrq)4
Total debt (mrq)51.62M
Total debt/equity (mrq)31.69%
Current ratio (mrq)3.06
Book value per share (mrq)4.06

Cash flow statement

Operating cash flow (ttm)-10.29M
Levered free cash flow (ttm)-9.69M